Direct measurement of low-density-lipoprotein cholesterol is more effective than total cholesterol for the purpose of lipoprotein screening

Preventive Medicine

Volumn 32, Issue 3, 2001, Pages 224-229

  Okada, Masahiko ^a   Ishida, Riichiro ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Direct measurement; Lipoprotein screening; Low density lipoprotein cholesterol

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0035712496     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.2000.0805     Document Type: Article

References (31)

1. The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
2. Cholesterol and lipids in the risk of coronary artery disease: The Framingham Heart study
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
5. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study
6. Helsinki heart study: Primary-prevention trial with gem-fibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease
7. Effect of simvastatin on coronary atheroma: The multicentre anti-atheroma study (MAAS)
8. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland coronary prevention study (WOSCOPS)
9. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent events trial
10. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
11. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
12. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
13. Low-density lipoprotein cholesterol can be chemically measured: A new superior method
14. Screening for total cholesterol: Do the National Cholesterol Education Program's recommendations detect individuals at high risk of coronary heart disease?
15. Fast lipoprotein chromatography: New method of analysis for plasma lipoproteins
16. Lipoprotein profiling by high performance gel chromatography
17. Accurate direct determination of low-density lipoprotein cholesterol using an enzymatic cholesterol assay
18. Comparison of an immunoprecipitation method for direct measurement of LDL cholesterol with beta-quantification (ultracentrifugation)
19. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated
20. Variability in cholesterol measurements: Comparison of calculated and direct LDL cholesterol determinants
21. Direct measurement of serum low-density lipoprotein cholesterol in patients with acute myocardial infarction on admission to the emergency room
22. Comparison of methods for measurement of apolipoprotein B and cholesterol in low-density lipoproteins
23. Direct measurement of LDL cholesterol
24. Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states
25. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary
26. Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects
27. Low-density lipoprotein particle size and coronary artery disease
28. LDL size and subclass pattern in a biethnic population
29. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects
30. The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentage of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
31. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines